🇺🇸 FDA
Patent

US 9084809

Immunogenic capsule composition for use as a vaccine component against Campylobacter jejuni

granted A61KA61K2039/6037A61K31/715

Quick answer

US patent 9084809 (Immunogenic capsule composition for use as a vaccine component against Campylobacter jejuni) held by United States of America as represented by the Secretary of the Air Force expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/6037, A61K31/715, A61K39/105, A61K47/6415